Completed OBSERVATIONAL NCT04126187

AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study

Sponsor: Gainesville Eye Associates

Conditions Cataract

Interventions Panoptix

Updated 11 times since 2019 Last updated: Sep 19, 2023 Started: May 14, 2020 Primary completion: Mar 30, 2021 Completion: Mar 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04126187, this observational or N/A phase trial focuses on Cataract and remains completed. Sponsored by Gainesville Eye Associates, it has been updated 11 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Oct 2023 — Jul 2024 [monthly]

Completed
Jan 2023 — Oct 2023 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed

▶ Show 6 earlier versions

Sep 2021 — Dec 2022 [monthly]

Completed

Status: Enrolling By Invitation → Completed
Mar 2021 — Sep 2021 [monthly]

Enrolling By Invitation
Jan 2021 — Mar 2021 [monthly]

Enrolling By Invitation
Aug 2020 — Jan 2021 [monthly]

Enrolling By Invitation
Feb 2020 — Aug 2020 [monthly]

Enrolling By Invitation
Nov 2019 — Feb 2020 [monthly]

Enrolling By Invitation

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gainesville Eye Associates
Science in Vision

Data source: Gainesville Eye Associates

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gainesville, United States